View in EDS

Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.

Saved in:
Bibliographic Details
Title: Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.
Authors: Chatzipli, Aikaterini1 (AUTHOR), Bonnefoi, Hervé2 (AUTHOR), MacGrogan, Gaetan2 (AUTHOR), Sentis, Julie2 (AUTHOR), Cameron, David3 (AUTHOR), Poncet, Coralie4 (AUTHOR), EORTC 10994/BIG 1-00 Consortium (AUTHOR), Abadie-Lacourtoisie, Sophie5 (AUTHOR), Bodmer, Alexandre6 (AUTHOR), Brain, Etienne7 (AUTHOR), Cufer, Tanja8 (AUTHOR), Campone, Mario9 (AUTHOR), Luporsi, Elisabeth10 (AUTHOR), Moldovan, Cristian11 (AUTHOR), Petit, Thierry12 (AUTHOR), Piccart, Martine13 (AUTHOR), Priou, Franck14 (AUTHOR), Senkus, Elsbieta15 (AUTHOR), Zaman, Khalil16 (AUTHOR), Iggo, Richard2 (AUTHOR) Richard.Iggo@u-bordeaux.fr
Source: British Journal of Cancer. Nov2021, Vol. 125 Issue 10, p1356-1364. 9p.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/s41416-021-01526-3